Latest Regulatory Approvals News

Redcastle Resources has formed a strategic joint venture with BML Ventures to fast-track gold production at its Queen Alexandra and Redcastle Reef deposits, while expanding its Eastern Goldfields footprint through major tenement acquisitions.

Cobalt Blue Holdings advances its Kwinana Cobalt Refinery with a critical Works Approval and secures letters of intent covering 70% of initial production, while its Broken Hill Cobalt Project gains a three-year Major Project Status extension.

Bioxyne Limited has reported a record-breaking first quarter for FY26, with revenues soaring 210% year-on-year, driven by strong demand in cannabis products and strategic European market advances.

VHM Limited has secured approval for its Cultural Heritage Management Plan at the Goschen Project, clearing a vital regulatory hurdle and enabling formal lodgement of its Work Plan to progress development.

Trigg Minerals has initiated the process for a Nasdaq dual listing via an American Depositary Receipt program, aiming to tap into the world’s largest capital market. The company also raised A$2.5 million from Tribeca Investment Partners, reinforcing its growth strategy.

Firebrick Pharma is set to expand its Nasodine product line with the launch of a new throat spray, targeting export markets starting November 2025, beginning with Singapore.

Anax Metals has made significant progress on its Whim Creek Copper-Zinc project, securing a waste rock processing agreement and continuing efforts to finalize project financing.

Magnetite Mines has made significant strides in developing its Razorback Iron Ore Project, securing $3.86 million in new funding and uncovering promising rare earth mineralisation at Ironback Hill. The company continues to navigate strategic partnerships and regulatory approvals to advance its long-life magnetite project.

Cleo Diagnostics has successfully completed Stage 1 of the Medical Device Single Audit Program, marking a significant step toward FDA submission and global commercialisation of its ovarian cancer test.

OncoSil Medical reports a remarkable 917% increase in quarterly cash receipts alongside promising clinical trial results and key European market entries, signaling robust momentum in its pancreatic cancer treatment rollout.

Vintage Energy reported a 24% drop in quarterly sales revenue to $0.9 million alongside a 20% production decline, while initiating a Production Uplift Program targeting its Southern Flank gas fields and maintaining steady 2P reserves at 12.5 MMboe.

Terragen Holdings expands its probiotic product range into beef and lamb feedlots, secures key international approvals, and progresses large-scale trials while maintaining a $3 million cash reserve.